UIRM

COMPANY REGISTRATION NO.
2007/028599/08

NPO NO.
095-120

PBO NO.
9252677167

Projects

Image is not available
Slider

First-in-human Clinical Validation and Feasibility of the Salus FLOW TB Urine LAM Assay for diagnosing active Tuberculosis in South Africa.

Collaborator: University of Washington

Funder: Salus Discovery

Principal Investigators: Dr P Drain & Dr DPK Wilson

Current Projects

Prospective Evaluation of Novel Diagnostics for Tuberculosis in KwaZulu-Natal South Africa

[fluid][html tag_input_style="bootstrapinput-9"]Pr...

Improving, detection and management of acute kidney injury (AKI) in low and middle income countries

Improving, detection and management of acute kidne...

First-in-human Clinical Validation and Feasibility of the Salus FLOW TB Urine LAM Assay for diagnosing active Tuberculosis in South Africa.

First-in-human Clinical Validation and Feasibility...

Mechanisms of HIV disease and limitation and cure revealed in paediatric infection

Mechanisms of HIV disease and limitation and cure ...

More From: Projects

Previous Projects

Umndeni Family Care Program in KwaZulu Natal, funded by the Massachusetts General Hospital

Umndeni Family Care Program in KwaZulu Natal, funded by the Massachusetts General Hospital The Umndeni Care Program provided community-based, in-home HIV counselling and testing, linkage to care and ...

Trends in C-Reactive Protein, D-Dimer, and Fibrinogen during Therapy for HIV-Associated Multidrug-Resistant Tuberculosis

Trends in C-Reactive Protein, D-Dimer, and Fibrinogen during Therapy for HIV-Associated Multidrug-Resistant Tuberculosis Patrick G. T. Cudahy, Joshua L. Warren, Ted Cohen, Douglas Wilson The America...

Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial

Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial Akur ...

Soluble CD14 as a Diagnostic Biomarker for Smear-Negative HIV-Associated Tuberculosis

Soluble CD14 as a Diagnostic Biomarker for Smear-Negative HIV-Associated Tuberculosis Yanyan Liu, Okechukwu C. Ndumnego, Tingting Chen, Ryung S. Kim, Elizabeth R. Jenny-Avital, Thumbi Ndung’u, Dougla...

Genomic diversity in autopsy samples reveals within-host dissemination of HIV-associated Mycobacterium tuberculosis

Genomic diversity in autopsy samples reveals within-host dissemination of HIV-associated Mycobacterium tuberculosis Tami D Lieberman, Douglas Wilson, Reshma Misra, Lealia L Xiong, Prashini Moodley, T...

Within-Host Heterogeneity of Mycobacterium tuberculosis Infection Is Associated With Poor Early Treatment Response: A Prospective Cohort Study

Within-Host Heterogeneity of Mycobacterium tuberculosis Infection Is Associated With Poor Early Treatment Response: A Prospective Cohort Study Ted Cohen, Leonid Chindelevitch, Reshma Misra, Maria E. ...

Antibodies against Mycobacterial Proteins as Biomarkers for HIV-Associated Smear-Negative Tuberculosis

Antibodies against Mycobacterial Proteins as Biomarkers for HIV-Associated Smear-Negative Tuberculosis Michael Siev, Douglas Wilson, Supreet Kainth, Victoria O. Kasprowicz, Catherine M. Feintuch, Eli...

The Prevalence and Drug Sensitivity of Tuberculosis among Patients Dying in Hospital in KwaZulu-Natal, South Africa: A Postmortem Study

The Prevalence and Drug Sensitivity of Tuberculosis among Patients Dying in Hospital in KwaZulu-Natal, South Africa: A Postmortem Study Ted Cohen, Megan Murray, Kristina Wallengren, Gonzalo G. Alvare...

Consumption of Sutherlandia frutescens by HIV-Seropositive South African Adults: An Adaptive Double-Blind Randomized Placebo Controlled Trial

Consumption of Sutherlandia frutescens by HIV-Seropositive South African Adults: An Adaptive Double-Blind Randomized Placebo Controlled Trial Douglas Wilson, Kathy Goggin Karen Williams, Mary M. Gerk...

Performance of Serum C-Reactive Protein as a Screening Test for Smear-Negative Tuberculosis in an Ambulatory High HIV Prevalence Population

Performance of Serum C-Reactive Protein as a Screening Test for Smear-Negative Tuberculosis in an Ambulatory High HIV Prevalence Population Douglas Wilson, Motasim Badri, Gary Maartens. PLOS│One htt...

More From: Previous Collaborations

footer image2